The phenomenon of pseudoprogression in cancer immunotherapy: is everything so unambiguous?

The phenomenon of pseudoprogression in cancer immunotherapy: is everything so unambiguous?

When evaluating the effect of therapy for malignant neoplasms with inhibitors of CTLA-4, PD-1 and PD-L1, the phenomenon of pseudoprogression may occur. Pseudoprogression is an increase in the volume of tumor tissue due to immunocompetent cells (lymphocytes, macrophages) mobilized into the tumor focu...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Vladislav O. Sarzhevskiy, Vladimir Ia. Melnichenko, Irina V. Panshina, Nikita E. Mochkin, Vladimir S. Bogatyrov, Maria M. Borshevetskaya, Elena G. Smirnova, Anna E. Bannikova, Anastasia A. Samoylova, Aysel A. Mamedova, Anatolij A. Rukavitsin, Sergei S. Vasilev, Oleg Iu. Bronov
Format: article
Langue:RU
Publié: IP Habib O.N. 2021
Sujets:
immunotherapy
pseudoprogression
ctla-4
pd-1
pd-l1 inhibitors
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Accès en ligne:https://doaj.org/article/087c99ed4f454995bde9965434ae6e7f
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/087c99ed4f454995bde9965434ae6e7f

Documents similaires